Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: Results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 1, 2013, Pages 10-14

  Barnes, Geoffrey D ^a,f   Kaatz, Scott ^b   Golgotiu, Vlad ^a   Gu, Xiaokui ^a   Leidal, Adam ^a   Kobeissy, Abdallah ^b   Haymart, Brian ^a   Kline Rogers, Eva ^a   Kozlowski, Jay ^c   Almany, Steve ^d   Leyden, Tom ^e   Froehlich, James B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c Huron Valley Sinai Hospital   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e Blue Cross Blue Shield of Michigan Cardiovascular Consortium   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anticoagulation; Orthopedic surgery; Venous thromboembolism; Warfarin

Indexed keywords

WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HIP ARTHROPLASTY; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNEE ARTHROPLASTY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SKIN BLEEDING; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MICHIGAN; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84871756451     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0766-y     Document Type: Article

References (14)

1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edn). Chest 133:381S-453S
2. Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358:9-15
3. Cohen AT, Bailey CS, Alikhan R, Cooper DJ (2001) Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty a meta-analysis. Thromb Haemost 85:940-941
4. Prandoni P, Bruchi O, Sabbion P, Tanduo C, Scudeller A, Sardella C et al (2002) Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 162:1966-1971
5. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V et al (2009) American academy of orthopaedic surgeons clinical practice guideline on. prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 91:1756-17577
6. Rosemont, IL (ed) (2011) Preventing venous thromboembolis disease in patients undergoing elective hip and knee arthroplasty: evidence-based guideline and evidence report 2nd edn American Academy of Orthopaedic Surgeons
7. Markel DC, York S, Liston MJ Jr, Flynn JC, Barnes CL, Davis CM III (2010) Venous thromboembolism: management by American association of hip and knee surgeons. J Arthroplasty 25(3-9):e1-2
8. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S et al (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e278S-325S
9. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236-239
10. Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692-694
11. Mismetti P, Laporte S, Zufferey P, Epinat M, Decousus H, Cucherat M (2004) Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost 2:1058-1070
12. Dahl OE, Quinlan DJ, Bergqvist D, Eikelboom JW (2010) A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost 8:1966-1975
13. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162:1833-1840
14. Becattini C, Lignani A, Agnelli G (2010) New anticoagulants for the prevention of venous thromboembolism. Drug Des Dev Ther 4:49-60